179 related articles for article (PubMed ID: 9555954)
1. Three-fold effect of lovastatin treatment on low density lipoprotein metabolism in subjects with hyperlipidemia: increase in receptor activity, decrease in apoB production, and decrease in particle affinity for the receptor. Results from a novel triple-tracer approach.
Berglund L; Witztum JL; Galeano NF; Khouw AS; Ginsberg HN; Ramakrishnan R
J Lipid Res; 1998 Apr; 39(4):913-24. PubMed ID: 9555954
[TBL] [Abstract][Full Text] [Related]
2. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.
Forster LF; Stewart G; Bedford D; Stewart JP; Rogers E; Shepherd J; Packard CJ; Caslake MJ
Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202
[TBL] [Abstract][Full Text] [Related]
3. Physiologic mechanisms of action of lovastatin in nephrotic syndrome.
Aguilar-Salinas CA; Barrett PH; Kelber J; Delmez J; Schonfeld G
J Lipid Res; 1995 Jan; 36(1):188-99. PubMed ID: 7706943
[TBL] [Abstract][Full Text] [Related]
4. Altered apolipoprotein B metabolism in very low density lipoprotein from lovastatin-treated guinea pigs.
Berglund LF; Beltz WF; Elam RL; Witztum JL
J Lipid Res; 1994 Jun; 35(6):956-65. PubMed ID: 8077853
[TBL] [Abstract][Full Text] [Related]
5. Lovastatin decreases de novo cholesterol synthesis and LDL Apo B-100 production rates in combined-hyperlipidemic males.
Cuchel M; Schaefer EJ; Millar JS; Jones PJ; Dolnikowski GG; Vergani C; Lichtenstein AH
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1910-7. PubMed ID: 9351353
[TBL] [Abstract][Full Text] [Related]
6. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
7. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production.
Arad Y; Ramakrishnan R; Ginsberg HN
J Lipid Res; 1990 Apr; 31(4):567-82. PubMed ID: 2351867
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors.
Bisgaier CL; Essenburg AD; Auerbach BJ; Pape ME; Sekerke CS; Gee A; Wölle S; Newton RS
J Lipid Res; 1997 Dec; 38(12):2502-15. PubMed ID: 9458274
[TBL] [Abstract][Full Text] [Related]
9. Effects of lovastatin therapy on guinea pig low density lipoprotein composition and metabolism.
Berglund L; Sharkey MF; Elam RL; Witztum JL
J Lipid Res; 1989 Oct; 30(10):1591-600. PubMed ID: 2614261
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
[TBL] [Abstract][Full Text] [Related]
11. Reduction of LDL production rate in ileal bypassed rabbits treated with lovastatin.
Lombardi P; Maggi FM; Maione G; Catapano AL
Pharmacol Res; 1991 Feb; 23(2):129-37. PubMed ID: 2062789
[TBL] [Abstract][Full Text] [Related]
12. ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm.
Fisher WR; Zech LA; Stacpoole PW
Arterioscler Thromb; 1994 Apr; 14(4):501-10. PubMed ID: 8148348
[TBL] [Abstract][Full Text] [Related]
13. Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models.
Krause BR; Newton RS
Atherosclerosis; 1995 Oct; 117(2):237-44. PubMed ID: 8801869
[TBL] [Abstract][Full Text] [Related]
14. Effect of simvastatin on receptor-dependent low density lipoprotein catabolism in normocholesterolemic human volunteers.
Malmendier CL; Lontie JF; Delcroix C; Magot T
Atherosclerosis; 1989 Dec; 80(2):101-9. PubMed ID: 2610723
[TBL] [Abstract][Full Text] [Related]
15. Influence of lovastatin therapy on metabolism of low density lipoproteins in mixed hyperlipidaemia.
Vega GL; Grundy SM
J Intern Med; 1991 Oct; 230(4):341-50. PubMed ID: 1919427
[TBL] [Abstract][Full Text] [Related]
16. Effects of stigmastanyl-phosphocholine (Ro 16-6532) and lovastatin on lipid and lipoprotein levels and lipoprotein metabolism in the hamster on different diets.
Himber J; Missano B; Rudling M; Hennes U; Kempen HJ
J Lipid Res; 1995 Jul; 36(7):1567-85. PubMed ID: 7595080
[TBL] [Abstract][Full Text] [Related]
17. Increased clearance of low density lipoprotein precursors in patients with heterozygous familial defective apolipoprotein B-100: a stable isotope approach.
Pietzsch J; Wiedemann B; Julius U; Nitzsche S; Gehrisch S; Bergmann S; Leonhardt W; Jaross W; Hanefeld M
J Lipid Res; 1996 Oct; 37(10):2074-87. PubMed ID: 8906585
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB.
Telford DE; Edwards JY; Lipson SM; Sutherland B; Barrett PH; Burnett JR; Krul ES; Keller BT; Huff MW
J Lipid Res; 2003 May; 44(5):943-52. PubMed ID: 12562847
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hydroxymethylglutaryl coenzyme A reductase activity does not affect the secretion rate of apolipoproteins B and AI by CaCo-2 cells.
Pau E; He Y; Lougheed M; Steinbrecher UP
Biochem Cell Biol; 1995; 73(1-2):81-90. PubMed ID: 7662319
[TBL] [Abstract][Full Text] [Related]
20. Estrogen increases low-density lipoprotein receptor-independent catabolism of apolipoprotein B in hyperlipidemic rabbits.
Colvin PL
Metabolism; 1996 Jul; 45(7):889-96. PubMed ID: 8692027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
